What is Refined Technologies?
Refined Technologies specializes in developing and supplying innovative products for cell culture applications. Its core offerings include the CORe Cell Culture System and CleanLine Connectors, alongside various connector assemblies and accessories engineered to enhance laboratory efficiency. The company primarily serves the biotechnology and life sciences sectors, catering to organizations involved in cell biology and bioprocessing. Refined Technologies actively engages in industry events to showcase its advanced solutions and foster connections with potential clientele, positioning itself as a key player in laboratory efficiency and bioprocessing innovation.
How much funding has Refined Technologies raised?
Refined Technologies has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
What's next for Refined Technologies?
The recent major strategic investment of $2M positions Refined Technologies for substantial expansion and further product development. Given the enterprise-level funding context, the company is likely to focus on scaling its operations, enhancing its manufacturing capabilities, and potentially broadening its market reach within the biotechnology and life sciences industries. Future strategic initiatives may include research into next-generation cell culture technologies and strengthening its distribution networks to meet growing global demand for efficient laboratory solutions.
See full Refined Technologies company page
